As-needed steroid therapy seems OK for mild asthma
Key points
- For patients with mild persistent Asthma, using inhaled or oral corticosteroids on an as-needed basis, rather than continuously, may be an option for keeping their condition under control, according to a new report.
- Daily steroid therapy is currently recommended for people with mild persistent asthma, but analysis of prescription patterns suggest that many patients are using steroid drugs only when symptoms arise.
- To see if this might be a reasonable approach, Dr.
- They were randomly assigned to an as-needed steroid regimen or daily steroid therapy for 1 year.
For patients with mild persistent Asthma, using inhaled or oral corticosteroids on an as-needed basis, rather than continuously, may be an option for keeping their condition under control, according to a new report.
Daily steroid therapy is currently recommended for people with mild persistent asthma, but analysis of prescription patterns suggest that many patients are using steroid drugs only when symptoms arise.
To see if this might be a reasonable approach, Dr. Homer A. Boushey of the University of California at San Francisco, and colleagues studied 225 Asthma patients.
They were randomly assigned to an as-needed steroid regimen or daily steroid therapy for 1 year. Some intermittent-steroid users were also given a different type of asthma control medication, zafirlukast, to take daily.
The three treatments produced similar increases in morning peak expiratory flow, and rates of asthma flare-ups were similar. This was the case despite little use of the inhaled steroid in the as-needed group, the team reports in this week's New England Journal of Medicine.
In a related editorial, Dr. Leonardo M. Fabbri, from the Policlinico di Modena in Italy, comments that the new findings may change clinical practice "since the option of intermittent treatment with inhaled corticosteroids complies with the philosophy of achieving and maintaining control of Asthma with the least amount of medication."
SOURCE: New England Journal of Medicine, April 14, 2005.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Lungs, Asthma & Allergies →NewsAllergen Immunotherapy Evolves as Faster, Safer and Longer-Lasting Treatment
Time-tested for a century, allergen immunotherapy has evolved into revolutionary methods of administration, as well as faster, safer and longer-lasting treatments according to the latest research presented at the Annual…
11 November 2007
NewsSpleen May Be Target of Successful Therapy for Lupus
Researchers at the University of California, San Diego (UCSD) School of Medicine have found clues that might lead to better treatment of lupus, showing that the spleen is the likely source of cells that are the origin…
15 September 2006
NewsInhaled Corticosteroids Reduce Death in Patients with COPD
Patients with chronic obstructive pulmonary disease (COPD) who use inhaled corticosteroids may have a significantly decreased mortality risk, according to a new study published in the September issue of CHEST, the…
